influx. VEGF also increased Mn 2ϩ influx after perfusion with thapsigargin, whereas ATP did not. These data showed that VEGF increased [Ca 2ϩ ] i and L p even when Ca 2ϩ stores were depleted and under conditions that prevented ATP-mediated increases in [Ca 2ϩ ] i and L p . This suggests that VEGF acts through a Ca 2ϩ store-independent mechanism, whereas ATP acts through Ca 2ϩ store-mediated Ca 2ϩ influx. vascular endothelial growth factor; vascular permeability; endothelial calcium; calcium stores; intracellular calcium concentration; adenosine 5Ј-triphosphate THE VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) family of polypeptides is a series of powerful chemokines that act on the microcirculation to increase delivery of nutrients to tissues (1) . They perform this function through three main mechanisms of action. Acutely, they act as vasodilators and hence decrease vascular resistance and increase blood flow to tissue (24) . They also result in increased microvascular permeability, both acutely over a period of a few minutes and chronically over a period of days. In addition, they are highly angiogenic and result in the formation of new blood vessels from an existing microvasculature (1) . All three of these mechanisms that result in increased solute delivery occur through direct activation of microvascular endothelial cells in arterioles (vasodilatation), capillaries (angiogenesis and increased permeability), and venules (increased permeability). These growth factors have been shown to be critically upregulated in a variety of pathological conditions associated with angiogenesis and permeability, including all solid tumors so far investigated, diabetic retinopathy, psoriasis, and rheumatoid arthritis (1) . They are currently being investigated as angiogenic stimulators to enable revascularization of underperfused tissue after myocardial infarction and in peripheral ischemia (20) .
The mechanisms of actions of VEGF are now beginning to be elucidated. VEGFs have been shown to bind to three receptors: flt-1 (VEGFR-1), flk1/KDR (VEGFR-2), and flt-4 (VEGFR-3, found only on lymphatic endothelial cells) (30) . Stimulation of these receptor tyrosine kinases results in phosphorylation and activation of phospholipase C-␥ (PLC-␥), both in vivo (28) and in vitro (36) , and so results in production of inositol 1,4,5-trisphosphate (IP 3 ) and diacylglycerol (7) in large-vessel endothelial cells in vitro. VEGF has been shown to increase endothelial intracellular calcium concentration ([Ca 2ϩ ] i ) by increasing Ca 2ϩ influx across the plasma membrane in endothelial cells in vitro (7) , and this Ca 2ϩ influx across the plasma membrane is responsible for the increase in permeability seen in vivo (4) . Increased [Ca 2ϩ ] i has previously been shown to result in increased microvascular permeability (16) through Ca 2ϩ -dependent activation of nitric oxide (NO) synthase (15) and subsequent production of NO and cGMP (17) , and both of these have also been shown to be produced after VEGF stimulation (24) .
Many of the signaling pathways stimulated by VEGF in endothelial cells in culture and some of those in vivo have therefore been identified. It is far less clear which of these pathways actually results in the increase in permeability and increased [Ca 2ϩ ] i . We have previously shown that the VEGF-mediated increase in permeability is dependent on stimulation of Ca 2ϩ influx across the plasma membrane (4) (26) . The sarcoendoplasmic reticulum Ca 2ϩ -ATPase (SERCA) pumps Ca 2ϩ from the cytoplasm into the endoplasmic reticulum. There is a slow but steady leak of Ca 2ϩ from the stores into the cytoplasm, so inhibition of this protein by use of thapsigargin results in a steady depletion of Ca 2ϩ stores. Although thapsigargin has been extensively used in endothelial (and other) cells in culture, there has been only one study to date investigating the effect of thapsigargin on [Ca 2ϩ ] i of endothelial cells of the microvasculature in vivo (37) . Therefore, we also investigated the effect of thapsigargin on endothelial [Ca 2ϩ ] i and permeability. Some of these results have previously been published as abstracts (2, 34) .
METHODS
Frog preparation. All experiments were carried out on male leopard frogs (20-35 g ). Hydraulic conductivity (L p ) measurements were made in Rana temporaria supplied by Blades, and Ca 2ϩ measurements were made in Rana pipiens supplied by J. M. Hazen, V.T. All chemicals were purchased from Sigma unless otherwise specified. ATP was perfused at 30 M and VEGF at 1 nM, because these doses have previously been shown to give a reproducible increase in both [Ca 2ϩ ] i and L p . Thapsigargin (Calbiochem) was perfused at 100 nM, because this has been shown to effectively inhibit SERCA in a variety of animal species and does not result in inhibition of other Ca 2ϩ pumps. Measurement of L p . Frogs were anesthetized by immersion in 1 mg/ml MS-222 (3-aminobenzoic acid ethyl ester) in water, and anesthesia was maintained by superfusion of the gut with 0.1-0.25 mg/ml MS-222 in frog Ringer solution (111 mM NaCl, 2.4 mM KCl, 1 mM MgSO 4 , 1.1 mM CaCl 2 , 0.20 mM NaHCO 3 , 2.63 mM HEPES acid, and 2.37 mM HEPES sodium salt). The pH of this solution was 7.40 Ϯ 0.02 at room temperature. The animal was laid supine, and the limbs were secured lightly. A small incision (8-10 mm) was made in the right lateral skin and muscular body wall. The distal ileum was floated out and carefully draped over a 1-cm-diameter transparent quartz pillar. The microvessels in the mesentery were visualized under a inverted microscope (Leica DMIL). A video camera (Panasonic WVBP32, 8 mm) was attached to the top of the microscope to allow for binocular visualization and simultaneous recording of a 270-m segment of the vessel (out of a total length of 800-2,000 m). The video was connected through an electronic timer (ForA VT33) to a video cassette recorder (Panasonic AG7350; Panasonic, Bracknell, UK). The upper surface of the mesentery was kept continuously superfused with frog Ringer solution during the entire time that it was exposed. All experiments were carried out at room temperature (20-22°C) . At the end of the experiment, the frog was killed by destruction of the cranium.
The L p of perfused mesenteric microvessels was measured by use of the Landis microocclusion method previously described (27) , which has been extensively discussed in the literature (10) and adapted to measure rapid changes in L p (3) . Baseline L p was defined as the conductivity during perfusion with 1% BSA in frog Ringer solution, adjusted to pH 7.4 with 0.115 M NaOH. Microvessels were selected that contained freely flowing blood, had no white cells adhering to or rolling along the wall, were at least 800-m long with no side branches, and had a baseline L p of Ͻ10 ϫ 10
. Microvessels chosen for L p measurement were either true capillaries (divergent flow at one end and convergent at the other) or first-order venules (convergent flow from two true capillaries at one end and convergent flow at the other) and had a diameter of 12-30 m (we have previously shown that permeability responses to VEGF are not dependent on vessel size, see Ref.
3). Glass micropipettes were manufactured from pulled capillary tubes (outer diameter 1.5 mm, Clark ElectroMed) and beveled to form a sharp tip 10-17 m in diameter. The vessel was cannulated with a micropipette filled with 1% BSA in frog Ringer solution and rat red blood cells as flow markers. The rat red blood cells were collected by direct cardiac puncture of 5% halothaneanesthetized rats and were washed three times in frog Ringer solution before use. Rats were killed by cervical dislocation while still anesthetized. The micropipette was clamped in a holder (WPI, Stevenage) and connected to a water manometer. The pipette was refilled with solution when required by use of a refilling system based on that described by Neal (29) . L p was measured by occluding the vessel with a glass rod for 3-7 s while perfusing at a pressure of 30 cmH 2 O. The vessel was then allowed to flow freely for at least 7 s before another occlusion was made. Refilling was observed as a change in the hematocrit of the perfusate, and the vessel was occluded immediately for 3-5 s as soon as possible to measure L p . The occlusion was released, and L p could then be measured approximately every 10 s. L p measurements were performed every 10-20 s during perfusion with test compounds. All perfusates contained rat red blood cells as flow markers.
Calculation of L p . The transcapillary water flow per unit area of capillary wall (J v /S) was calculated from the initial velocity of the red blood cells (dl/dt, change in length over change in time) after occlusion, the capillary radius (r), and the length between the marker cell and the point of occlusion (l), all of which were measured offline from the videotape
The L p was calculated from the Starling equation
where ⌬P is the effective hydrostatic and oncotic pressure difference between the capillary and the interstitium. The capillary pressure was set at 30 cmH 2 O, so ⌬P was 26.4 cmH 2 O (1% BSA has an effective oncotic pressure of 3.6 cmH 2 O), with the assumption that tissue pressure was negligible, and tissue oncotic pressure was equivalent to that in the superfusate (zero).
Measurement of [Ca 2ϩ ] i . [Ca 2ϩ ] i was measured in frog mesenteric microvessels as previously described (4) . In brief, the frog was pithed and laid supine, and the limbs were secured to a supporting tray. The abdominal cavity was opened by making incisions on both sides of the trunk and across the midline. The body wall flap was then lifted back over the upper body to expose the viscera, which were held in place by cotton wool soaked in Ringer. The mesentery was floated over a glass coverslip attached to the supporting tray and held in place by pinning of the gut to the edge of the coverslip. This allowed for observation of a perfused microvessel with the short working distance lens necessary for fluorescence measurement. The upper surface of the mesentery was continuously superfused with Ringer, and the temperature of the superfusate was kept at 20-22°C. Vessels chosen for cannulation were postcapillary venules (first-, second-, and third-order venules) of diameter 25-40 m. Vessels were visualized under an epifluorescence microscope (Leitz Diavert) equipped with quartz optics in the excitation pathway, a photomultiplier tube (Leitz MPV) and excitation filter changer (Kinetek) under computer control, and a 100-W mercury lamp. A selected vessel was cannulated and perfused with 1% BSA in Ringer. Fluorescence intensity (I f ), collected by a dry Fluotar lens (20ϫ, numerical aperture 0.75), was measured from a window 150-m long and 40-m wide that was placed ϳ200 m downstream of the cannulation site. I f values at excitation wavelengths of 340 Ϯ 5 and 380 Ϯ 5 nm (selected by 2 narrow band interference filters) and emission at 500 Ϯ 35 nm were collected by use of a 0.25-s exposure to give an initial background I f for each vessel that could be used to estimate fura loading. All I f values were measured during perfusion at a pressure of 30 cmH 2 O. The vessel was then perfused with frog Ringer containing 5 M fura 2-AM and 1% BSA for 60-120 min in the dark. The vessel was briefly examined during this time by illumination with 380-nm light to check that even loading was occurring. Once the I f had reached 6-10ϫ background, the vessel was perfused for 10 min with 1% BSA to give a baseline Ca 2ϩ reading.
After the baseline I f was measured, the vessel was perfused with various pharmacological agents (see RESULTS) in Ringer containing 1% BSA. Finally, the vessel was perfused with 1% BSA containing 5 mM MnCl 2 and nominally 0 M Ca 2ϩ . This final perfusion quenched the fluorescence, presumably from the Ca 2ϩ -sensitive form of fura 2, and a second background intensity reading was taken. However, we noticed that the rate of quench appeared to be much slower after perfusion with thapsigargin. We therefore measured the rate of quenching after perfusion with Mn 2ϩ , by measurement of I f at 360-nm excitation (I f 360 ; see DISCUSSION). After the final I f measurement was made, the animal was killed by decapitation. Vessels were accepted that had a diffuse fluorescence throughout the endothelial cells, with more intense fluorescence around the nuclei (due to increased cell thickness around the nucleus), and a I f at least 6ϫ background.
Calculation of [Ca 2ϩ ] i . [Ca 2ϩ ] i was calculated from the equation (16, 35) 
where R is the normalized ratio of I f calculated as
where R exp ϭ (I f 340 Ϫ B 340 )/(I f 380 Ϫ B 380 ). I f 340 is the I f with excitation at 340 nm, I f 380 is the I f with excitation at 380 nm, and B 340 and B 380 are the background I f values at excitations of 340 and 380 nm, respectively (measured as the I f after Mn 2ϩ quenching). R max is the in vitro ratio at saturating Ca 2ϩ concentration normalized to R min . R min is the in vitro ratio for zero Ca 2ϩ concentration, and K is the product of the effective dissociation constant for fura 2 and the ratio of the in vitro I f 380 for zero and saturating Ca 2ϩ . K was estimated from an in vitro calibration curve for fura 2, as previously described (4) .
Data analysis and statistics. To compare responses of different vessels, individual readings from single vessels were normalized relative to baseline and then time averaged in 15-s (for L p measurement) or 10-s (for [Ca 2ϩ ] i measurement) bins, starting immediately after perfusion with agonist. The means Ϯ SE of the time-averaged measurements for all the vessels within that group were then calculated. The peak of the time-averaged data was therefore always lower than the actual peak value for the vessel, by definition. The mean peak values for the vessel will therefore be greater than the timeaveraged and vessel-averaged [Ca 2ϩ ] i and L p . Multiple-way comparisons of data were carried out using ANOVA with Bonferroni post hoc tests. Two-way comparisons of data were carried out using paired t-tests. Where data were not normally distributed, a Friedman test was performed to provide significance for repeated measures, with Dunn's post hoc tests. ] i then returned to control values until it reached a significantly lower (P Ͻ 0.001) sustained concentration of 105 Ϯ 14 nM after an additional 5 min, which was not significantly different from the concentration before thapsigargin (not significant, Fig. 2 ).
RESULTS

Effect of inhibition of
Twelve additional vessels were perfused with thapsigargin, and L p was measured. A representative trace is shown in Fig. 2B . Thapsigargin perfusion resulted in a transient increase in L p to 12.8 Ϯ 2.8-fold greater than baseline (33 Ϯ 11 from 4.1 Ϯ 1.9 ϫ 10
, P Ͻ 0.01; Fig. 2C, right) . The L p then returned to control values over the following 5-10 min and reached an average of 4.1 Ϯ 1.5 ϫ 10
, which was not significantly different from the baseline L p (P Ͼ 0.05).
Effect of thapsigargin on the increase in L p brought about by VEGF. Measurements of L p were made on nine vessels perfused with 1 nM VEGF ( Table 1) . Perfusion with VEGF caused an immediate and transient 5.4 Ϯ 1.1-fold increase in L p , as previously described (P Ͻ 0.05, paired t-test). VEGF was then washed out for 20 min to prevent further responses being masked by the tachyphylaxis previously described. After 20-min perfusion with thapsigargin, L p was not significantly different from control. Subsequent perfusion with 1 nM VEGF in the presence of thapsigargin caused a rapid 7.5 Ϯ 2.7-fold increase in L p , which was on average not significantly different from the response to VEGF before thapsigargin perfusion (P Ͼ 0.05). The time-averaged responses to VEGF in the presence and absence of thapsigargin are shown in Fig. 3A . These results are in marked contrast to those obtained with ATP. Figure 3B shows time-averaged data of L p measurements made in seven vessels perfused with ATP, with and without pretreatment with thapsigargin. Perfusion of vessels with ATP before thapsigargin stimulated a rapid 5.4 Ϯ 0.6-fold increase in L p , from a mean baseline of 3.8 Ϯ 1.4 to a peak of 19 Ϯ 4.9 ϫ 10
The L p then returned toward control values (7.9 Ϯ 3.1 ϫ 10
, P Ͼ 0.05 compared with baseline before ATP). After 20-min perfusion with thapsigargin, ATP perfusion did not increase L p (1.1 Ϯ 0.1-fold, P Ͻ 0.001 vs. the increase before thapsigargin), from a base of 8.1 Ϯ 3.0 (P Ͼ 0.05 vs. before thapsigargin) to a peak of 8.9 Ϯ 3.2 ϫ 10 Ϫ7 cm ⅐ s Ϫ1 ⅐ cmH 2 O Ϫ1 (P Ͼ 0.05 vs. base). Some representative traces of L p data are shown in Fig. 4 . Figure 4A shows that L p increases in response to VEGF with and without thapsigargin perfusion. Figure 4B shows a vessel in which L p was measured during perfusion with ATP; it was then perfused with thapsigargin for 20 min and then with ATP, and L p was measured, followed by washout with thapsigargin and BSA; and L p was then measured during perfusion of the same vessel with VEGF. In this and two other vessels similarly perfused, no increase in L p was seen during perfusion with ATP, whereas subsequent perfusion of the same vessel with VEGF resulted in a significant transient increase in L p . Furthermore, the effect of a different SERCA inhibitor, cyclopiazonic acid (CPA), on the VEGF-and ATP-mediated increased permeability was also examined in one vessel (see Fig.  4C ). ATP did not increase L p in the presence of CPA, whereas VEGF resulted in a significant transient increase in L p in that same vessel. CPA therefore had the same effect as thapsigargin. Finally, to ensure that Ca 2ϩ stores had been depleted, we perfused one vessel with thapsigargin and 1 M ionomycin to stimulate release from stores. Once the L p had returned toward control values, we then perfused that vessel with VEGF. VEGF still gave a typical transient increase in permeability (Fig. 4D) . ] i , from 85 Ϯ 20 to 296 Ϯ 90 nM (P Ͻ 0.001), which was, on average, not significantly different from that before thapsigargin (P Ͼ 0.05). The time-averaged increase in Ca 2ϩ across all nine vessels is shown in Fig. 5A (time-averaged data will not show the full extent of the increase in Ca 2ϩ because each measurement in each vessel is the average of 4 Ca 2ϩ measurements, only 1 of which could have been the peak response). It can be seen that there was no significant difference in the VEGF response whether thapsigargin was present or absent. ] i ) before and during vascular endothelial growth factor (VEGF; n ϭ 9 vessels) or ATP (n ϭ 7 vessels) perfusion with and without thapsigargin (TG) pretreatment. * Significantly greater than base (P Ͻ 0.05). Table 1 ) and not significantly different from the baseline (P Ͼ 0.05). Perfusion of the vessel with thapsigargin significantly attenuated the ATP-mediated [Ca 2ϩ ] i increase, suggesting that perfusion with 100 nM thapsigargin resulted in Ca 2ϩ store depletion.
Effect of thapsigargin on the increase in [Ca
In three vessels, both VEGF and ATP were given with thapsigargin sequentially. These traces are shown in Fig. 6 . Figure 6A shows that in a single vessel, VEGF increases [Ca 2ϩ ] i with thapsigargin at least as effectively as it did before thapsigargin. ATP did not increase [Ca 2ϩ ] i in the presence of thapsigargin, but VEGF was still able to increase [Ca 2ϩ ] i in the continued presence of thapsigargin, even after exposure to ATP. Figure 6B shows ] i in endothelial cells in vivo by use of fluorescent indicator dyes such as fura 2, it was necessary to determine the background I f by quenching the Ca 2ϩ -sensitive fura 2. To do this, at the end of the experiment, the vessels were perfused with Mn 2ϩ , which enters cells through Ca 2ϩ channels and quenches the Ca 2ϩ -sensitive indicator. The rate of quench of the indicator is a measure of the rate of Mn 2ϩ influx (and, by inference, Ca 2ϩ influx across the plasma membrane). We noticed that the rate of quench with thapsigargin appeared to be slower than usual. We therefore investigated the change in the rate of quench stimulated by VEGF and ATP to determine whether VEGF or ATP could indeed stimulate quenching of fura 2. At the end of the experiments to measure Ca 2ϩ changes, the vessels were perfused with frog Ringer, which was nominally Ca 2ϩ free and contained 5 mM Mn 2ϩ and 1% BSA. The I f 360 (the isosbestic point for fura 2, the wavelength at which there is no Ca 2ϩ sensitivity) was then measured for 10-20 s. Four vessels were perfused with 1% BSA with Mn 2ϩ and then 1 nM VEGF with 1% BSA and Mn 2ϩ . In another four vessels, vessels were perfused with the 1% BSA and Mn 2ϩ ; then with 1% BSA, Mn 2ϩ , and 30 M ATP; and then with 1% BSA, Mn 2ϩ , and 1 nM VEGF. I f 360 was measured for 10-20 s after each cannulation.
The rate of quench of a single vessel is expressed in Fig. 7 as the I f as a proportion of the initial intensity ionophore) and 100 nM TG to ensure depletion of Ca 2ϩ stores. Once L p had returned to control values, the vessel was perfused with 1 nM VEGF, which increased permeability despite store depletion.
(I 0 ). The slope of the curve is proportional to the rate of Mn 2ϩ entry. It can be seen from Fig. 7 that perfusion of a vessel with 30 M ATP did not significantly increase the rate of quench of the dye, i.e., perfusion with 30 M ATP in the presence of thapsigargin did not result in increased Ca 2ϩ influx. However, perfusion with VEGF did increase the rate of quench and resulted in a rapid, complete quench. VEGF was therefore capable of stimulating Ca 2ϩ influx in the presence of thapsigargin, whereas ATP could not. Quench rates were measured for 1% BSA and VEGF in four vessels and for BSA, ATP, and VEGF in four vessels. The quench rates for BSA and ATP were not different from each other [1.0 Ϯ 0.2%/s for BSA (n ϭ 8) and 1.3 Ϯ 0.7%/s for ATP (n ϭ 4)] but were significantly higher during VEGF perfusion [7.6 Ϯ 5.3%/s (n ϭ 8), P Ͻ 0.01 compared with both ATP and BSA].
DISCUSSION
The ability to increase [Ca 2ϩ ] i was one of the first effects of VEGF described during its initial purification (8). Although VEGF has been shown to result in increased [Ca 2ϩ ] i and permeability in a variety of systems (4, 7), the mechanisms by which these are brought about have not been extensively investigated. The experiments described here are the first investigation of the mechanism of that increase in [Ca 2ϩ ] i . We proposed three hypotheses for the mechanism of increased [Ca 2ϩ ] i . These were 1) the release of Ca 2ϩ from intracellular stores, 2) Ca 2ϩ release-activated Ca 2ϩ influx across the plasma membrane, or 3) store-independent Ca 2ϩ influx across the plasma membrane. Our data are consistent only with the third hypothesis, that VEGF increases [Ca 2ϩ ] i by a store-independent mechanism of Ca 2ϩ influx across the plasma membrane. The permeability effects of both VEGF and ATP have been shown to be dependent on Ca 2ϩ influx in vivo (4). It has been assumed, therefore, that they increase permeability through the same mechanism. The experiments described here show that VEGF-induced increases in permeability are not affected by store depletion with SERCA inhibitors. This finding was in marked contrast to the increase in permeability mediated by ATP, which was significantly attenuated by store depletion. These data support the novel hypothesis that VEGF increases [Ca 2ϩ ] i and microvascular permeability through a mechanism distinct from the increases evoked by ATP.
The mechanism of VEGF-stimulated Ca 2ϩ influx. Of the three likely explanations for the VEGF-mediated increase in [Ca 2ϩ ] i , our data are only consistent with the hypothesis that the increase in [Ca 2ϩ ] i is due to Ca 2ϩ influx rather than store release. This hypothesis is also consistent with previous data showing that the increase in permeability brought about by VEGF can also be inhibited by perfusion with nickel (4 (21) has previously shown that agonists that stimulate Ca 2ϩ influx in endothelial cells in culture result in increased rate of quench of fura 2. The experiments described here were not specifically designed to measure Ca 2ϩ influx (we do not have data on the rate of quench of vessels not perfused with thapsigargin, for instance) and cannot be used to determine general mechanisms regulating Ca 2ϩ influx. However, the observation that VEGF stimulates the rate of quenching of fura 2 by Mn 2ϩ in the presence of thapsigargin but ATP did not increase Mn 2ϩ influx, strongly suggests that VEGF acts to increase Ca 2ϩ influx through a pathway which is different from that stimulated by ATP (22) .
VEGF and ATP act through different mechanisms. ATP is known to stimulate P 2Y purinoreceptors, which results in IP 3 production and release of Ca 2ϩ from endoplasmic reticulum (33) . It is this release of Ca 2ϩ from intracellular stores that stimulates Ca 2ϩ entry through a passive conductance pathway, possibly by hyperpolarization of the endothelial cell by stimulation of Ca 2ϩ -activated potassium channels (K Ca ) (9) . Our data suggest that the Ca 2ϩ influx resulting from stimulation of endothelial cells with ATP in vivo is brought about by release of Ca 2ϩ from intracellular stores, in the same manner as it is in vitro. It has previously been shown that the permeability increase caused by ATP is also dependent on activation of Ca 2ϩ influx. The increase in permeability is dependent on extracellular Ca 2ϩ and can be inhibited by reducing the driving force for Ca 2ϩ influx (18) . It may be hypothesized that inhibition of the stimulus for Ca 2ϩ influx, the release of Ca 2ϩ from intracellular stores, would inhibit the permeability increase. Figure 3B shows that perfusion with thapsigargin for 20 min successfully inhibited the permeability increase brought about by ATP. This shows that the conditions described here effectively blocked store-dependent, Ca 2ϩ influx-mediated permeability increases. They serve as useful controls to differentiate between store-dependent and -independent increases in permeability.
The VEGF-mediated increase in [Ca 2ϩ ] i and L p is consistent with the hypothesis that VEGF acts through a store-independent mechanism. Stimulation of Ca 2ϩ influx independently of release from internal stores has been shown to occur through at least three classes of plasma membrane Ca 2ϩ channels. These include voltage-operated Ca 2ϩ channels, which are not present in endothelial cells either in culture or in vivo (9, 31); receptor-operated Ca 2ϩ channels, which do not include any of the known VEGF receptors (30) ; and second messenger-operated, store-independent Ca 2ϩ channels (6) . The discovery of store-independent Ca 2ϩ channels is currently proceeding apace with the cloning and characterization of novel Trp channels (32) . TrpC3 and TrpC6 Ca 2ϩ channels have recently been described as being activated by second messengers such as diacylglycerol (19) , which is known to be produced by VEGF stimulation, but it is not known whether these channels are activated by VEGF. They have been shown to be activated by other growth factors acting on tyrosine kinase receptors, however (25) . The identification of the channels through which VEGF stimulates Ca 2ϩ influx may provide a target for drug design to target conditions associated with VEGF over-or underproduction, including all tumors, diabetic retinopathy, and heart disease.
Effect of thapsigargin on [Ca 2ϩ ] i and vascular permeability. Thapsigargin has been extensively used in many studies of endothelial [Ca 2ϩ ] i regulation. However, all of the studies where endothelial [Ca 2ϩ ] i has been measured during exposure to thapsigargin have been carried out in cultured endothelial cells (usually from large arteries or veins), with the exception of one study, which measured [Ca 2ϩ ] i in endothelial cells of the lung microvasculature in situ (37) . This study unfortunately did not measure Ca 2ϩ changes during thapsigargin perfusion but showed that Ca 2ϩ waves were inhibited by thapsigargin perfusion. The data presented here are therefore the first description of the effects of SERCA inhibitors on [Ca 2ϩ ] i in intact endothelial cells of vessels in vivo. Figure 2 shows that thapsigargin perfusion into microvessels causes a transient increase in [Ca 2ϩ ] i . This is similar in some respects to the effect of thapsigargin on endothelial cells in vitro (11) but also differs in one important aspect. Application of thapsigargin to endothelial cells in vitro results in a transient increase in [Ca 2ϩ ] i , which peaks at approximately the same level as described here (400 Ϯ 110 nM) and does not return to the control values but maintains a high sustained level (11) . This sustained increase is 70% of the peak increase. This is significantly greater than the sustained level measured in this study, which is only 8 Ϯ 10% of the peak increase (P Ͻ 0.05). This finding implies that Ca 2ϩ store depletion does not result in a sustained [Ca 2ϩ ] i increase in endothelial cells in vivo. Possible differences between in vivo and in vitro settings include the extent to which Ca 2ϩ extrusion is activated and the contribution of K Ca to the regulation of membrane hyperpolarization and hence part of the driving force for Ca 2ϩ entry (14) . The finding that store depletion does not result in a sustained increase in [Ca 2ϩ ] i is somewhat contradictory to our expectation, and this question deserves further attention. However, the mechanisms linking the thapsigargin-induced Ca 2ϩ release to the time course of change in [Ca 2ϩ ] i and L p are not the focus of this investigation.
The experiments described in this paper show that the VEGF-mediated increase in [Ca 2ϩ ] i in endothelial cells in vivo can be attenuated by inhibition of Ca 2ϩ influx. The increase in [Ca 2ϩ ] i and the associated increase in L p occur even after Ca 2ϩ store depletion. This is in direct contrast to the increases in permeability and [Ca 2ϩ ] i brought about by ATP, which were inhibited by store depletion. In addition, VEGF but not ATP stimulated Mn 2ϩ entry into endothelial cells after store depletion. VEGF therefore acts through a different signaling pathway from ATP, and this evidence suggests that VEGF acts to increase [Ca 2ϩ ] i , Ca 2ϩ influx and microvascular permeability through a Ca 2ϩ storeindependent mechanism.
